Terms: = Colorectal cancer AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck AND Treatment
10 results:
1. Enriching Chemical Space of Bioactive Scaffolds by New Ring Systems: Benzazocines and Their Metal Complexes as Potential Anticancer Drugs.
Kuznetcova I; Ostojić M; Gligorijević N; Aranđelović S; Arion VB
Inorg Chem; 2022 Dec; 61(50):20445-20460. PubMed ID: 36473464
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of adoptively transferred allogeneic CIK cells on colorectal cancer: Augmentative antitumoral effects of GvHD.
Muhammadnejad S; Monzavi SM; Torabi-Rahvar M; Sotoudeh M; Muhammadnejad A; Tavakoli-Shiraji S; Ranjbar A; Aghayan SS; Khorsand AA; Moradzadeh K; Janzamin E; Ahmadbeigi N
Int Immunopharmacol; 2023 Jan; 114():109446. PubMed ID: 36463696
[TBL] [Abstract] [Full Text] [Related]
3. Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor.
Yokoyama Y; Lew ED; Seelige R; Tindall EA; Walsh C; Fagan PC; Lee JY; Nevarez R; Oh J; Tucker KD; Chen M; Diliberto A; Vaaler H; Smith KM; Albert A; Li G; Bui JD
Cancer Res; 2019 Apr; 79(8):1996-2008. PubMed ID: 30723115
[TBL] [Abstract] [Full Text] [Related]
4. Potential biomarkers for the early diagnosis of colorectal adenocarcinoma - transcriptomic analysis of four clinical stages.
Janikowska G; Janikowski T; Pyka-Pająk A; Mazurek U; Janikowski M; Gonciarz M; Lorenc Z
Cancer Biomark; 2018; 22(1):89-99. PubMed ID: 29562499
[TBL] [Abstract] [Full Text] [Related]
5. Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors.
Montero JC; Seoane S; Ocaña A; Pandiella A
Clin Cancer Res; 2011 Sep; 17(17):5546-52. PubMed ID: 21670084
[TBL] [Abstract] [Full Text] [Related]
6. Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis.
Gardini A; Ercolani G; Riccobon A; Ravaioli M; Ridolfi L; Flamini E; Ridolfi R; Grazi GL; Cavallari A; Amadori D
J Surg Oncol; 2004 Jul; 87(1):46-52. PubMed ID: 15221919
[TBL] [Abstract] [Full Text] [Related]
7. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
[TBL] [Abstract] [Full Text] [Related]
8. Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients.
Ridolfi R; Flamini E; Riccobon A; De Paola F; Maltoni R; Gardini A; Ridolfi L; Medri L; Poletti G; Amadori D
Cancer Immunol Immunother; 1998 Jun; 46(4):185-93. PubMed ID: 9671141
[TBL] [Abstract] [Full Text] [Related]
9. Differential expression of two classes of lck transcripts upon phorbol ester treatment of human leukemic T cells.
Leung S; Miyamoto NG
J Cell Physiol; 1991 Sep; 148(3):344-52. PubMed ID: 1918168
[TBL] [Abstract] [Full Text] [Related]
10. Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells.
Foss FM; Veillette A; Sartor O; Rosen N; Bolen JB
Oncogene Res; 1989; 5(1):13-23. PubMed ID: 2476706
[TBL] [Abstract] [Full Text] [Related]
